Sugi Holdings Co (7649) AI Stock Analysis

• Market Cap: $635.54B
• Dividend Yield: 0.98%
• Average Volume (3M): 538.82K
• Price to Earnings (P/E): 15.5
• Beta (1Y): 0.16
• Revenue Growth: 20.18%
• EPS Growth: 82.36%
• Country: JP
• Employees: 8,724
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 117.28
• Shares Outstanding: 189,992,510
• 10 Day Avg. Volume: 559,360
• 30 Day Avg. Volume: 538,823
• PEG Ratio: 1.13
• Price to Book (P/B): 1.95
• Price to Sales (P/S): 0.56
• P/FCF Ratio: 36.72
• Enterprise Value/Market Cap: 0.83
• Enterprise Value/Revenue: 0.57
• Enterprise Value/Gross Profit: 1.82
• Enterprise Value/Ebitda: 8.68
• 1Y Price Target: $4,354.89
• Price Target Upside: 28.88% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 63 Neutral
• Price Target: ¥3,591.00 ▲(6.27% Upside)

The overall stock score for Sugi Holdings Co is driven primarily by its strong financial performance, which is offset by bearish technical indicators. The valuation is fair, but the lack of positive momentum and absence of earnings call insights or corporate events limit the score.

Sugi Holdings Co Business Overview & Revenue Model

Company Description

Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides visiting nursing services and home care support services. As of June 1, 2019, the company operated 1,190 stores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.

How the Company Makes Money

Sugi Holdings Co. makes money primarily through the sale of pharmaceuticals, cosmetics, and daily necessities in its retail stores across Japan. Its revenue model is based on the retail markup of these products. The company also engages in the wholesale of pharmaceuticals, which contributes to its earnings. A significant portion of its revenue comes from prescription drugs, supported by its network of in-store pharmacists who provide consultation services. Additionally, Sugi Holdings leverages partnerships with pharmaceutical manufacturers and suppliers to optimize its product offerings and pricing. The company also benefits from its loyalty programs and marketing strategies aimed at increasing customer retention and attracting new customers.

Sugi Holdings Co Financial Statement Overview

Summary

Sugi Holdings Co exhibits a solid financial performance with strong revenue growth, stable profit margins, and robust cash flow generation. The balance sheet is stable with a conservative debt profile, indicating low financial risk.

Income Statement

Sugi Holdings Co has demonstrated strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit margin and net profit margin have been stable, reflecting efficient cost management. EBIT and EBITDA margins are healthy, suggesting robust operational performance. The company's consistent revenue growth trajectory is a positive sign for future profitability.

Balance Sheet

The company's balance sheet reflects a strong equity position with a stable debt-to-equity ratio, indicating a conservative leverage strategy. The equity ratio is healthy, suggesting a solid financial foundation. However, there was a minor increase in total liabilities, which should be monitored for potential risks. Overall, the balance sheet suggests financial stability and low financial risk.

Cash Flow

Sugi Holdings Co has shown a strong free cash flow growth rate, indicating improved cash generation capabilities. The operating cash flow to net income ratio is stable, reflecting efficient cash management. The company has maintained a positive free cash flow to net income ratio, highlighting its ability to generate cash relative to its profitability. Cash flow trends suggest robust liquidity and financial flexibility.

Breakdown	TTM	Dec 2024	Dec 2024	Dec 2022	Dec 2022	Dec 2021
Income Statement
Total Revenue	922.52B	744.48B	878.02B	625.48B	667.65B	602.51B
Gross Profit	290.66B	228.84B	275.04B	191.49B	202.52B	181.29B
EBITDA	60.96B	46.24B	56.18B	38.74B	40.56B	41.48B
Net Income	40.79B	21.98B	25.69B	19.39B	19.01B	21.12B
Balance Sheet
Total Assets	540.12B	390.56B	495.12B	334.76B	351.89B	345.93B
Cash, Cash Equivalents and Short-Term Investments	87.98B	47.43B	52.79B	71.83B	70.64B	95.84B
Total Debt	43.61B	837.00M	45.35B	2.31B	1.95B	2.26B
Total Liabilities	271.55B	157.20B	244.41B	120.87B	135.36B	145.30B
Stockholders Equity	268.57B	233.36B	250.70B	213.89B	216.54B	200.63B
Cash Flow
Free Cash Flow	0.00	6.34B	13.31B	-16.20B	16.77B	12.46B
Operating Cash Flow	0.00	39.04B	36.94B	7.17B	38.28B	34.03B
Investing Cash Flow	0.00	-30.98B	-33.28B	-23.89B	-23.26B	-29.25B
Financing Cash Flow	0.00	-5.28B	11.63B	-5.29B	-14.21B	-5.27B

Sugi Holdings Co Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3379.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7649, the sentiment is Negative. The current price of 3379 is below the 20-day moving average (MA) of 3714.40, below the 50-day MA of 3745.10, and above the 200-day MA of 3094.71, indicating a neutral trend. The MACD of -73.96 indicates Positive momentum. The RSI at 25.53 is Positive, neither overbought nor oversold. The STOCH value of 9.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7649.

Sugi Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3391	78 Outperform	¥564.62B	26.01	7.73%	17.29%	4.63%	-47.30%
3141	72 Outperform	¥551.23B	30.26	6.02%	1.35%	7.43%	-24.81%
9989	69 Neutral	¥492.01B	15.82	11.40%	3.09%	6.64%	6.38%
7649	63 Neutral	$635.54B	15.51	16.26%	0.98%	20.18%	82.36%
3349	63 Neutral	¥661.47B	21.79	12.03%	0.84%	4.81%	26.65%
3549	63 Neutral	¥397.68B	22.84	12.20%	0.37%	15.81%	27.05%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Sugi Holdings Co Corporate Events

Sugi Holdings Reports Strong Sales Growth in June 2025

Sugi Holdings Co., Ltd. reported a 4.7% increase in sales for existing stores in June 2025, with the drugstore business growing by 2.9% and the prescription business by 11.8%. On an all-store basis, sales rose by 17.0%, driven by a 6.9% increase in the drugstore segment and a significant 57.6% rise in prescription sales. The company opened 8 new stores and closed 10, resulting in a total of 2,204 stores by the end of June, reflecting its strategic adjustments in the market.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Revises Financial Forecasts Upward Amid Strong Sales

Sugi Holdings Co., Ltd. has revised its financial forecasts for the fiscal year ending February 2026, following increased sales in the first quarter and the recording of additional deferred tax assets. The upward revision reflects a positive outlook on net sales, operating profit, and ordinary profit, driven by a merger within its subsidiaries and a strategic focus on capturing market demand.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Reports Strong Financial Growth for Q1 2025

Sugi Holdings Co., Ltd. reported a significant increase in its financial performance for the three months ended May 31, 2025, with net sales rising by 22.1% and profit attributable to owners of the parent increasing by 246.6% compared to the previous year. The company also revised its consolidated earnings forecast for the fiscal year ending February 28, 2026, reflecting a positive outlook despite the exclusion of I&H Co., Ltd. following an absorption-type merger with Sugi Pharmacy Co., Ltd.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Completes Treasury Stock Disposition

SUGI Holdings Co., Ltd. has completed the payment procedures for the disposition of treasury stock as restricted stock remuneration, a decision made by its Board of Directors on May 27, 2025. This move involves the distribution of 7,044 shares of common stock to various directors and executive officers, amounting to a total disposition value of 22,195,644 yen, potentially impacting the company’s financial strategy and stakeholder interests.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Maintains Independence Amid Significant Shareholder Ownership

SUGI Holdings Co., Ltd. has disclosed information regarding Sugi Shoji Co., Ltd., which holds 37.43% of its voting rights. Despite this significant ownership, Sugi Shoji does not impose any restrictions on SUGI Holdings’ business activities, and there are no plans to change this arrangement, ensuring stability in the company’s operations and management.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Announces Treasury Stock Disposition for Executive Incentives

SUGI Holdings Co., Ltd. has announced a resolution to dispose of 7,044 shares of its treasury stock as part of its restricted stock remuneration system. This initiative aims to incentivize directors and executive officers to enhance corporate value and align their interests with shareholders. The move is expected to strengthen the company’s governance and motivate key personnel by tying their compensation to the company’s stock performance.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.